ImmuCell Corporation (ICCC) Earnings Call Analysis

NASDAQ · Healthcare · Biotechnology

11/25

Growth 3 Margin 2 Expansion 2 Platform 0 Financial 4

latest quarter score

Earnings Reports

11
ImmuCell Corporation (ICCC) Q2 2026: 28% Distributor Volume Growth Signals Expanding Market Penetration
August 17, 2026
10
ImmuCell (ICCC) Q4 2025: TriShield Up 41% as First Defense Refocus Drives Strategic Reset
June 15, 2026
18
Immucell (ICCC) Q1 2026: Tri-Shield Drives 38% Growth, Capturing 80% of Market Expansion
May 15, 2026
11
EmuCell (ICCC) Q3 2025: Gross Margin Soars to 43% as Supply Constraints Ease
November 14, 2025
10
ICCC Q2 2025: Gross Margin Doubles to 44% as Backlog Clears, Setting Up Competitive Reset
August 15, 2025
15
ImmuCell Corporation (ICCC) Q1 2025: 11% Product Sales Growth Drives Record Quarterly Earnings
May 15, 2025

Browse all companies